This article reviews a new class of antiemetic agents, the neurokinin-1 (NK-1) receptor antagonists (RAs). Clinical trials of an NK-1 RA, aprepitant, are ongoing.
Not a current ONS member or journal subscriber?
Receive a PDF to download and print.
A New Class of Antiemetic Agents on the Horizon
has been added to your cart